fbpx

Nominees to the Silmo d’Or Awards 2019

Here is the nominees list to the 26th Silmo d’Or Awards:

FRAME TECHNOLOGICAL INNOVATION

DOKOMOTTO LUNETTERIE DE FRANCE WITH «COLLECTION NATURE»
FREISICHT WITH «AVANTGARDE»
L’AMY WITH «MCLAREN SUPER SERIES»
L’AMY TECHNOLOGIES WITH «HYPERION»
OBE WITH «SPACE SCREWS»

CHILDREN

BLANC … WITH «ARIANE»
CAROLINE ABRAM WITH «MINI DEAR» DE TETE A LUNETTES
COGAN WITH «ZOOBUG BUTTERFLY» – MONDOTTICA
Ki ET LA WITH «OURS’ON»
OPAL WITH «TARTINE & CHOCOLAT TC AA153»

OPTICAL FRAME «FASHION TREND»

AZZARO WITH «AZ30271» – GROSFILLEY
CHLOE WITH «CE2743» – MARCHON
MAJE WITH «MJ1023» – MONDOTTICA
MARNI WITH «ME2631» – MARCHON
VICTORIA BECKHAM WITH «VB2106» – MARCHON

SUNGLASSES «FASHION TREND»

CARRERA WITH «CARRERA FACER» – SAFILO
KARL LAGERFELD WITH «KL309S» – MARCHON
ON AURA TOUT VU WITH «BRONZE C01» -TONYSAME
SONIA RYKIEL WITH «ENDLESS SUMMER» – L’AMY
VICTORIA BECKHAM WITH «VB605S» – MARCHON

SPORT

DEMETZ WITH «CLIP & DIVE»
JULBO WITH «RUSH»
MICHAËL PACHLEITNER GROUP WITH «FLOW» – RED BULL SPECT EYEWEAR
SAFILO WITH «ATTACKMAGMTB» – SMITH

VISION

CONTACT LENSES

COOPER VISION WITH «MISIGHT 1 DAY»
JOHNSON & JOHNSON VISION WITH «ACUVUE®OASYS WITH TRANSITIONSTM»

LENSES

ABEYE WITH «LEXILENS»
ESSILOR WITH «ESSILOR EYEZEN START»
HOYA WITH «HOYALUX MYSELF»
NOVACEL WITH «VARIOVID VOLTERRA»
TRANSITIONS OPTICAL WITH «TRANSITIONS SIGNATURE GEN8»

MATERIAL / EQUIPMENT

BBGR WITH «LUMIZ ™ 100»
ESSILOR «EYEVIZ 300»
NIDEK WITH «ARK-F»

OPTICAL FRAME «EYEWEAR DESIGNER»

AOYAMA OPTICAL (FACTORY 900) WITH «RF-064»
JACQUES MARIE MAGE WITH «TRISTAN»
monogram EYEWEAR WITH «MNSO 010»
SPECIAL’EYES WITH «DRIVE» COLLECTION BRETT
TARIAN WITH «GRAPHIC»

SUNGLASSES «EYEWEAR DESIGNER»

CAROLINE ABRAM WITH «DIVINE»
ic! berlin WITH «BELLEVUE»
STEALER WITH «FINGER FRAME»
NATHALIE BLANC PARIS WITH «MAMAN»
TARIAN WITH «SACRÉ CŒUR»

LOW VISION

AXOS WITH «SNOW 12»
ESCHENBACH OPTIK WITH «VARIO DIGITAL»
VOXIWEB WITH «VOXIONE»

Source: Silmo Paris

Featured Posts

Fighting Blindness Canada research

Gene Therapy for Wet AMD: Phase 1/2 Clinical Trial Results

A new study published in The Lancet shared results from a Phase 1/2 clinical trial testing a one-time anti-VEGF gene therapy for wet age-related macular degeneration (wet AMD).

Learn More
CooperVision

CooperVision Hosts Canadian ECPs for Innovation Tour in Costa Rica

CooperVision recently hosted an Innovation Tour for 20 eye care professionals from across Canada at its state-of-the-art, LEED® certified manufacturing facility located in San José, Costa Rica.

Read more
The Centre for Eye and Vision Research (CEVR) and SCOPE Health Inc. logos

CEVR and SCOPE Health Sign a MoU to Develop and Commercialize Novel Product Technologies for the Treatment of Dry Eye and Ocular Surface Conditions

The Centre for Eye and Vision Research (CEVR) and SCOPE Health Inc. have announced the signing of a Memorandum of Understanding (MoU) to establish a collaborative partnership focused on developing innovative technologies for dry eye disease and other ocular surface conditions.

Read more
SightGlass Vision

Three New Peer Reviewed Papers Expand Myopia Management Evidence for SightGlass Vision Diffusion Optics Technology™

Works in BMJ Open Ophthalmology, Ophthalmic and Physiological Optics, and Translational Vision Science & Technology Focus on Efficacy, Vision, and Contrast Theory

Read more
Kappa Visibilia logos

VISIBILIA and Kappa® (BasicNet) Announce Exclusive Licensing Agreement

Visibilia and Kappa® have announced an exclusive licensing agreement for the design, production, and distribution of Kappa® eyewear.

Read more
Fighting Blindness Canada research

Gene Therapy for Wet AMD: Phase 1/2 Clinical Trial Results

A new study published in The Lancet shared results from a Phase 1/2 clinical trial testing a one-time anti-VEGF gene therapy for wet age-related macular degeneration (wet AMD).

Learn More
CooperVision

CooperVision Hosts Canadian ECPs for Innovation Tour in Costa Rica

CooperVision recently hosted an Innovation Tour for 20 eye care professionals from across Canada at its state-of-the-art, LEED® certified manufacturing facility located in San José, Costa Rica.

Read More
The Centre for Eye and Vision Research (CEVR) and SCOPE Health Inc. logos

CEVR and SCOPE Health Sign a MoU to Develop and Commercialize Novel Product Technologies for the Treatment of Dry Eye and Ocular Surface Conditions

The Centre for Eye and Vision Research (CEVR) and SCOPE Health Inc. have announced the signing of a Memorandum of Understanding (MoU) to establish a collaborative partnership focused on developing innovative technologies for dry eye disease and other ocular surface conditions.

Read More
SightGlass Vision

Three New Peer Reviewed Papers Expand Myopia Management Evidence for SightGlass Vision Diffusion Optics Technology™

Works in BMJ Open Ophthalmology, Ophthalmic and Physiological Optics, and Translational Vision Science & Technology Focus on Efficacy, Vision, and Contrast Theory

Read More
Kappa Visibilia logos

VISIBILIA and Kappa® (BasicNet) Announce Exclusive Licensing Agreement

Visibilia and Kappa® have announced an exclusive licensing agreement for the design, production, and distribution of Kappa® eyewear.

Read More
Fighting Blindness Canada research

Gene Therapy for Wet AMD: Phase 1/2 Clinical Trial Results

A new study published in The Lancet shared results from a Phase 1/2 clinical trial testing a one-time anti-VEGF gene therapy for wet age-related macular degeneration (wet AMD).

Learn More
CooperVision

CooperVision Hosts Canadian ECPs for Innovation Tour in Costa Rica

CooperVision recently hosted an Innovation Tour for 20 eye care professionals from across Canada at its state-of-the-art, LEED® certified manufacturing facility located in San José, Costa Rica.

Read more
The Centre for Eye and Vision Research (CEVR) and SCOPE Health Inc. logos

CEVR and SCOPE Health Sign a MoU to Develop and Commercialize Novel Product Technologies for the Treatment of Dry Eye and Ocular Surface Conditions

The Centre for Eye and Vision Research (CEVR) and SCOPE Health Inc. have announced the signing of a Memorandum of Understanding (MoU) to establish a collaborative partnership focused on developing innovative technologies for dry eye disease and other ocular surface conditions.

Read more
SightGlass Vision

Three New Peer Reviewed Papers Expand Myopia Management Evidence for SightGlass Vision Diffusion Optics Technology™

Works in BMJ Open Ophthalmology, Ophthalmic and Physiological Optics, and Translational Vision Science & Technology Focus on Efficacy, Vision, and Contrast Theory

Read more
Kappa Visibilia logos

VISIBILIA and Kappa® (BasicNet) Announce Exclusive Licensing Agreement

Visibilia and Kappa® have announced an exclusive licensing agreement for the design, production, and distribution of Kappa® eyewear.

Read more
Fighting Blindness Canada research

Gene Therapy for Wet AMD: Phase 1/2 Clinical Trial Results

A new study published in The Lancet shared results from a Phase 1/2 clinical trial testing a one-time anti-VEGF gene therapy for wet age-related macular degeneration (wet AMD).

Learn More
CooperVision

CooperVision Hosts Canadian ECPs for Innovation Tour in Costa Rica

CooperVision recently hosted an Innovation Tour for 20 eye care professionals from across Canada at its state-of-the-art, LEED® certified manufacturing facility located in San José, Costa Rica.

Read more
The Centre for Eye and Vision Research (CEVR) and SCOPE Health Inc. logos

CEVR and SCOPE Health Sign a MoU to Develop and Commercialize Novel Product Technologies for the Treatment of Dry Eye and Ocular Surface Conditions

The Centre for Eye and Vision Research (CEVR) and SCOPE Health Inc. have announced the signing of a Memorandum of Understanding (MoU) to establish a collaborative partnership focused on developing innovative technologies for dry eye disease and other ocular surface conditions.

Read more
SightGlass Vision

Three New Peer Reviewed Papers Expand Myopia Management Evidence for SightGlass Vision Diffusion Optics Technology™

Works in BMJ Open Ophthalmology, Ophthalmic and Physiological Optics, and Translational Vision Science & Technology Focus on Efficacy, Vision, and Contrast Theory

Read more
Kappa Visibilia logos

VISIBILIA and Kappa® (BasicNet) Announce Exclusive Licensing Agreement

Visibilia and Kappa® have announced an exclusive licensing agreement for the design, production, and distribution of Kappa® eyewear.

Read more